- Home
- PRTA vs MOV Comparison
PRTA vs MOV Comparison
Compare PRTA & MOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRTA
- MOV
- Stock Information
- Founded
- PRTA 2012
- MOV 1961
- Country
- PRTA Ireland
- MOV United States
- Employees
- PRTA N/A
- MOV N/A
- Industry
- PRTA Biotechnology: Pharmaceutical Preparations
- MOV Consumer Specialties
- Sector
- PRTA Health Care
- MOV Consumer Discretionary
- Exchange
- PRTA Nasdaq
- MOV Nasdaq
- Market Cap
- PRTA 472.1M
- MOV 339.1M
- IPO Year
- PRTA N/A
- MOV 1993
- Fundamental
- Price
- PRTA $8.20
- MOV $18.27
- Analyst Decision
- PRTA Buy
- MOV Strong Buy
- Analyst Count
- PRTA 10
- MOV 1
- Target Price
- PRTA $14.86
- MOV $31.50
- AVG Volume (30 Days)
- PRTA 1.2M
- MOV 145.4K
- Earning Date
- PRTA 08-04-2025
- MOV 08-28-2025
- Dividend Yield
- PRTA N/A
- MOV 7.66%
- EPS Growth
- PRTA N/A
- MOV N/A
- EPS
- PRTA N/A
- MOV 0.77
- Revenue
- PRTA $10,341,000.00
- MOV $655,597,000.00
- Revenue This Year
- PRTA N/A
- MOV $0.71
- Revenue Next Year
- PRTA $389.77
- MOV N/A
- P/E Ratio
- PRTA N/A
- MOV $23.68
- Revenue Growth
- PRTA N/A
- MOV 0.79
- 52 Week Low
- PRTA $4.32
- MOV $12.85
- 52 Week High
- PRTA $22.83
- MOV $24.47
- Technical
- Relative Strength Index (RSI)
- PRTA 58.73
- MOV 70.66
- Support Level
- PRTA $8.05
- MOV $16.75
- Resistance Level
- PRTA $8.73
- MOV $17.55
- Average True Range (ATR)
- PRTA 0.38
- MOV 0.49
- MACD
- PRTA -0.05
- MOV 0.20
- Stochastic Oscillator
- PRTA 47.62
- MOV 99.42
About PRTA Prothena Corporation plc
Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including ATTR amyloidosis [Coramitug (PRX004)], Alzheimer's disease (PRX123), Neurodegeneration (PRXPRX019), and Others.
About MOV Movado Group Inc.
Movado Group Inc designs, develops, sources, markets, and distributes fine watches in the United States and internationally. It operates through the Watch and Accessory Brands and Company Stores segment. The Watch and Accessory Brands segment includes the designing, manufacturing, and distribution of watches and, to a lesser extent, jewelry and other accessories of quality owned brands and licensed brands. Its Company Stores segment includes the company's retail outlet locations in the United States and Canada. It generates maximum revenue from the Watch and Accessory Brands segment. Geographically, it derives the majority of its revenue from its international locations.